Trial intelligence / Profile preview

Articaine infiltration versus lidocaine inferior alveolar nerve block for mandibular second molar pulpotomy

IRCT20170101031697N5Phase 3Completed

Sponsor
Hormozgan University of Medical Sciences
Start
Dec 2020
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial of articaine and lidocaine in pulpitis (2 arms), sponsored by Hormozgan University of Medical Sciences. Primary endpoint: Pain during anesthesia injection. Started Dec 2020; status: completed.

02

Drugs

articainelidocaine
03

Conditions

pulpitis

Beyond the preview

Go deeper on IRCT20170101031697N5.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20170101031697N5.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call